7
Participants
Start Date
June 30, 2006
Primary Completion Date
June 30, 2007
Study Completion Date
January 31, 2008
3-phthalimidoglutarimide (Thalidomide)
Thalidomide at 200 mg dosage bid was administered during a twelve month period.
National Council of Science and Technology, Mexico
OTHER
National Institute of Neurology and Neurosurgery, Mexico
OTHER